Pancreatic Cancer
Rexin-G, first tumor-targeted gene therapy vector, stymies chemo-resistant cancer
Published in Gene Therapy Weekly, December 7th, 2006
The milestone article, appearing in the International Journal of Oncology, reports on three clinical studies involving patients with various chemo-resistant tumor types who received Rexin-G in Phase I/II and expanded access protocols.
In the first study, progressive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-12-07)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Researchers from College of Medicine, Department of Microbiology discuss findings in cancer gene therapy - Cancer Gene Therapy
Researchers from Second Military Medical University, Department of Gastroenterology describe findings in cancer gene therapy - Chronic Lymphocytic Leukemia
Research from Moores Cancer Center provide new insights into chronic lymphocytic leukemia - DNA Vaccines
New DNA vaccines study findings recently were published by researchers at Peking Union Medical College, Medical College - DNA Vaccines
Studies in the area of DNA vaccines reported from Institute of Medical Education and Research, Department of Biochemistry - Gene Therapy
Data from University of Oklahoma, Health Science Center advance knowledge in gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
